Functional and structural characterization of the integrase from the prototype foamy virus
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Establishment of the stable provirus is an essential step in retroviral replication, orchestrated by integrase (IN), a virus-derived enzyme. Until now, available structural information was limited to the INs of human immunodeficiency virus type 1 (HIV-1), avian sarcoma virus (ASV) and their close orthologs from the Lentivirus and Alpharetrovirus genera. Here, we characterized the in vitro activity of the prototype foamy virus (PFV) IN from the Spumavirus genus and determined the three-dimensional structure of its catalytic core domain (CCD). Recombinant PFV IN displayed robust and almost exclusively concerted integration activity in vitro utilizing donor DNA substrates as short as 16 bp, underscoring its significance as a model for detailed structural studies. Comparison of the HIV-1, ASV and PFV CCD structures highlighted both conserved as well as unique structural features such as organization of the active site and the putative host factor binding face. Despite possessing very limited sequence identity to its HIV counterpart, PFV IN was sensitive to HIV IN strand transfer inhibitors, suggesting that this class of inhibitors target the most conserved features of retroviral IN-DNA complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Because retroviral IN active sites are highly conserved, INSTIs are broadly active across the retroviral family32,158,159 save the occasional example when an IN residue, such as Ser150 in ASLV IN, confers baseline resistance, in this case to elvitegravir39,160.”
From Structure and function of retroviral integrase (2022) · cites this paper as [158]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2008) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,804
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742 · cited 2×
“The final model containing 139 protein residues, 48 water molecules and one Mg atom was built using iterative cycles of real space refinement in COOT (61), simulated annealing/restrained refinement in PHENIX (62) and restrained refinement in REFMAC (63) against a highenergy remote dataset collected to 2.20 A ˚ at = 0.…”
MethodInfluentialWebLogo: A Sequence Logo Generator: Figure 1
Crooks, G. E., Hon, G., Chandonia, J.-M., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,386 · cited 1×
“The height of each logo is proportional to the frequency of the corresponding nucleotide within the alignment, while the height of each stack of logos reflects the level of conservation at each position. The figure was created using WebLogo ( 83 ).”
MethodScaling and assessment of data quality
Evans, P. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905036693 · Cited by 4,374
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
ESPript: analysis of multiple sequence alignments in PostScript.
Gouet, P., Courcelle, E., Stuart, D. I., & M√©toz, F. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.4.305 · Cited by 2,951 · cited 1×
“Residue numbering corresponds to HIV-1 IN. (A), (B), (D) and (E) were created with PyMOL (DeLano Scientific, http://www.pymol.org), and (C) with ESPript ( 84 ).”
MethodAutomated protein model building combined with iterative structure refinement.
Anastassis Perrakis, A., Morris, R. J., & Lamzin, V. S. (1999) · Nature Structural Biology · doi:10.1038/8263 · Cited by 2,431 · cited 1×
“The structure factors and phases were used as input to ARP/wARP (60) for automated model building.”
Method
Research works printed but not linked: 1
- Leslie AGW Recent changes to the MOSFLM package for processing film and image plate data Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography. 1992
Cited by
Retroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678
Self-citationThe structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
“The clinically approved HIV-1 IN inhibitor, raltegravir, and similar small molecules that are in development preferentially inhibit DNA strand transfer activity; fortuitously, IN strand transfer inhibitors (INSTIs) harbour broad antiretroviral activit”
BackgroundSelf-citationMolecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
“Presumably, tighter binding INSTIs would better compensate for the energetic penalty associated with reordering the active sites of mutant INs.”
BackgroundMethodInfluentialSelf-citationThe mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296
Self-citationHare, S., Smith, S. J., Métifiot, M., Jaxa-Chamiec, A., Pommier, Y., Hughes, S. H., & Cherepanov, P. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073189 · Cited by 264
“Although the IN active site is not fully structured in the absence of viral DNA, because of disorder of the flexible loop and the active site glutamic acid, the remainder of the local structure superposes remarkably well across retroviral genera (Valkov et al., 2009).”
BackgroundSelf-citationLesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Self-citationResistance to Integrase Inhibitors
Métifiot, M., Marchand, C., Maddali, K., & Pommier, Y. (2010) · Viruses · doi:10.3390/v2071347 · Cited by 99
“Nevertheless, raltegravir and elvitegravir also inhibit PFV IN in vitro [33], indicating that the active site of the PFV and HIV enzymes are quite similar.”
BackgroundMethodHindmarsh, P., & Leis, J. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.836-843.1999 · Cited by 202
Structure-based modeling of the functional HIV-1 intasome and its inhibition
Krishnan, L., Li, X., Naraharisetty, H. L., Hare, S., Cherepanov, P., & Engelman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002346107 · Cited by 191
“PFV intasome activity, as well as cell infection by PFV, is inhibited by RAL and EVG (41).”
BackgroundInfluentialSelf-citationHare, S., Shun, M.-C., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000259 · Cited by 166
“strongly depend on the in vitro reaction conditions, with parameters such as the length of the donor DNA, enzyme source and concentration, and presence of crowding agents greatly affecting the outcomes [22,39–41].”
BackgroundSelf-citationMolecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
“These studies in turn suggest that the overall architectures of different retroviral intasomes may exhibit significant resemblance with the PFV structure.”
MethodInfluential3′‐Processing and strand transfer catalysed by retroviral integrase in crystallo
Hare, S., Maertens, G. N., & Cherepanov, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.118 · Cited by 153
Self-citationGupta, S. S., Maetzig, T., Maertens, G. N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., & Schulz, T. F. (2013) · Journal of Virology · doi:10.1128/jvi.01942-13 · Cited by 139
“To clone FLAG-tagged deletion constructs for MLV IN, IN fragments were PCR amplified from pQMLV-IN-FLAG plasmid using the following primer pairs: IN(110-409) ( NTD), SG1 and PC595; IN(160-409) ( CCD), SG2 and PC595; IN(1-278) ( CTD), PC594 and SG3; IN(160359) ( CCD CTD), SG2 and SG4.”
MethodSelf-citationStructural basis for retroviral integration into nucleosomes
Maskell, D. P., Renault, L., Serrao, E., Lesbats, P., Matadeen, R., Hare, S., Lindemann, D., Engelman, A. N., Costa, A., & Cherepanov, P. (2015) · Nature · doi:10.1038/nature14495 · Cited by 138
Self-citationRetroviral Integrase Proteins and HIV-1 DNA Integration
Krishnan, L., & Engelman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.397760 · Cited by 97
“Recombinant PFV IN was amenable to intasome structural biology due to its inherent solubility in relatively low ionic strength buffer and its favorable DNA recombination properties (18, 35, 36).”
BackgroundStructural insights into the retroviral DNA integration apparatus
Cherepanov, P., Maertens, G. N., & Hare, S. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.12.005 · Cited by 118
Self-citationStructural biology of retroviral DNA integration
Li, X., Krishnan, L., Cherepanov, P., & Engelman, A. (2011) · Virology · doi:10.1016/j.virol.2010.12.008 · Cited by 112
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript The mechanism of INSTI action based on co-crystal structures with the PFV intasome Cell infection by PFV as well as PFV IN activity in vitro were importantly sensitive to inhibition by RAL and the related INSTI elvitegravir (EVG) (Valk…”
BackgroundMethodSelf-citationStructure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Self-citationStructural Basis for Functional Tetramerization of Lentiviral Integrase
Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000515 · Cited by 122
“ably crystallize as dimers, with isomorphous dimer interfaces [9– 11].”
BackgroundSelf-citationRetroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0024-2014 · Cited by 94
“INSTIs display generally broad-spectrum antiretroviral activity (56, 205, 206), and co-crystallization with the PFV CI accordingly revealed critical aspects of the mechanism of INSTI action (94, 207, 208).”
BackgroundMethodInfluentialSelf-citationThe Molecular Biology of HIV Integrase
Craigie, R. (2012) · Future Virology · doi:10.2217/fvl.12.56 · Cited by 108
“First, it is more soluble, and second, unlike HIV integrase, it readily assembles intasomes on short oligonucleotide DNA substrates [53].”
BackgroundA supramolecular assembly mediates lentiviral DNA integration
Ballandras-Colas, A., Maskell, D. P., Serrao, E., Locke, J., Swuec, P., Jónsson, S. R., Kotecha, A., Cook, N. J., Pye, V. E., Taylor, I. A., et al. (2017) · Science · doi:10.1126/science.aah7002 · Cited by 107
Self-citationPiecing together the structure of retroviral integrase, an important target in AIDS therapy
Jaskolski, M., Alexandratos, J. N., Bujacz, G., & Wlodawer, A. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07009.x · Cited by 83
“HIV-1 IN [48,49] and PFV IN [ 58 ], has an octahedral coordination sphere completed by four water molecules (Fig. 4B).”
BackgroundInfluentialMultifaceted HIV integrase functionalities and therapeutic strategies for their inhibition
Engelman, A. N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006901 · Cited by 78
“Fortuitously, both NRTIs and INSTIs, which target respective RT and IN active sites composed of invariant amino acid residues, inhibit a wide range of retroviruses (95–103) including spumaviruses (104, 105).”
BackgroundElvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143
Métifiot, M., Vandegraaff, N., Maddali, K., Naumova, A., Zhang, X., Rhodes, D., Marchand, C., & Pommier, Y. (2011) · AIDS · doi:10.1097/qad.0b013e3283473599 · Cited by 80
“The active site of the PFV and HIV enzymes are structurally and functionally related, and RAL as well as EVG is able to inhibit PFV integrase in vitro [13].”
BackgroundThe role of integration and clonal expansion in HIV infection: live long and prosper
Anderson, E. M., & Maldarelli, F. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0448-8 · Cited by 83
Evolution of Foamy Viruses: The Most Ancient of All Retroviruses
Rethwilm, A., & Bodem, J. (2013) · Viruses · doi:10.3390/v5102349 · Cited by 74
Billamboz, M., Bailly, F., Lion, C. J., Calmels, C., Andréola, M., Witvrouw, M., Christ, F., Debyser, Z., Luca, L. D., Chimirri, A., et al. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.033 · Cited by 64
Key determinants of target DNA recognition by retroviral intasomes
Serrao, E., Ballandras-Colas, A., Cherepanov, P., Maertens, G. N., & Engelman, A. N. (2015) · Retrovirology · doi:10.1186/s12977-015-0167-3 · Cited by 62
“However, because PFV [46] and HIV-1 [33] integration in vivo and using naked plasmid tDNA substrates in vitro generated similar palindrome signatures, the forces that govern the selection of particular bases at the sites of integration appear for the most part independent of tDNA chromatinization.”
BackgroundMethodSelf-citationEngelman, A. N., & Cherepanov, P. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.04.005 · Cited by 56
“Given that PFV IN is much more amenable to in vitro studies [4 ,31,32], Li et al.”
BackgroundSelf-citationSerrao, E., Krishnan, L., Shun, M.-C., Li, X., Cherepanov, P., Engelman, A., & Maertens, G. N. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku136 · Cited by 59
“PFV integration yields a 4-bp duplication of tDNA sequences (39).”
Self-citationHost Factors in Retroviral Integration and the Selection of Integration Target Sites
Craigie, R., & Bushman, F. D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0026-2014 · Cited by 45
The emerging diversity of transpososome architectures
Dyda, F., Chandler, M., & Hickman, A. B. (2012) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583512000145 · Cited by 49
“In contrast, PFV integrase is exclusively monomeric (Valkov et al. 2009).”
BackgroundEngineered Hyperactive Integrase for Concerted HIV-1 DNA Integration
Li, M., Jurado, K. A., Lin, S., Engelman, A., & Craigie, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105078 · Cited by 42
“Integration products were sequenced as described [14].”
Intasome architecture and chromatin density modulate retroviral integration into nucleosome
Benleulmi, M. S., Matysiak, J., Henriquez, D. R., Vaillant, C., Lesbats, P., Calmels, C., Naughtin, M., Leon, O., Skalka, A. M., Ruff, M., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0145-9 · Cited by 47
“HIV-1 IN was purified either from bacteria using the same procedure as described for PFV enzyme [47] either from yeast was purified as previously reported [65].”
MethodInfluentialCosnefroy, O., Tocco, A., Lesbats, P., Thierry, S., Calmels, C., Wiktorowicz, T., Reigadas, S., Kwon, Y., Cian, A. D., Desfarges, S., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05425-11 · Cited by 47
“Prototype foamy virus (PFV) integrase was purified according to the method reported before (41).”
MethodGupta, K., Curtis, J. E., Krueger, S., Hwang, Y., Cherepanov, P., Bushman, F. D., & Van Duyne, G. D. (2012) · Structure · doi:10.1016/j.str.2012.08.023 · Cited by 35
“The purification of full-length PFV IN (IN 1-392) was carried out as previously described (Valkov et al., 2009).”
MethodSelf-citationMolecular docking, QPLD, and ADME prediction studies on HIV-1 integrase leads
Tripathi, S. K., Selvaraj, C., Singh, S. K., & Reddy, K. K. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9940-6 · Cited by 44
“(Valkov et al., 2009).”
Lewis, M. G., Norelli, S., Collins, M., Barreca, M. L., Iraci, N., Chirullo, B., Yalley-Ogunro, J., Greenhouse, J. J., Titti, F., Garaci, E., et al. (2010) · Retrovirology · doi:10.1186/1742-4690-7-21 · Cited by 43
“These amino acids are also conserved in HIV-2 IN (susceptible to raltegravir [30]) but are not in prototype foamy virus (PFV; susceptible to raltegravir but showing EC50 values 1-2 orders of magnitude higher than the EC50 for HIV-1 [42]) or Rous sarcoma virus (RSV) IN (which is not inhibited by INSTIs designed for HIV…”
BackgroundThe HIV-1 Integrase Monomer Induces a Specific Interaction with LTR DNA for Concerted Integration
Pandey, K. K., Bera, S., & Grandgenett, D. P. (2011) · Biochemistry · doi:10.1021/bi201247f · Cited by 39
“Both complexes possess a tetramer of IN (6, 8, 9) that produces their respective HIV 5 bp (11, 12) and PFV 4 bp (13) host site duplications.”
BackgroundMethodInfluentialYin, Z., Lapkouski, M., Yang, W., & Craigie, R. (2012) · Protein Science · doi:10.1002/pro.2166 · Cited by 35
Different Pathways Leading to Integrase Inhibitors Resistance
Thierry, E., Deprez, E., & Delelis, O. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02165 · Cited by 40
“Similar susceptibilities between PFV-1 and HIV-1 INs, coupled with the PFV-1 structure, allowed to obtain information for a better comprehension of mechanisms involved in resistance (Valkov et al., 2009; Hare et al., 2010a).”
BackgroundStrategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
B′-protein phosphatase 2A is a functional binding partner of delta-retroviral integrase
Maertens, G. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1347 · Cited by 38
“(A) Scheme explaining concerted versus half-site integration (23).”
InfluentialGoethals, O., Ginderen, M. V., Vos, A. M., Cummings, M. D., der Borght, K. V., Wesenbeeck, L. V., Feyaerts, M., Verheyen, A., Smits, V., Loock, M. V., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.05.011 · Cited by 38
Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase
Sari, O., Roy, V., Métifiot, M., Marchand, C., Pommier, Y. G., Bourg, S., Bonnet, P., Schinazi, R. F., & Agrofoglio, L. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.09.015 · Cited by 38
Retroviral Integrase: Then and Now
Andrake, M., & Skalka, A. M. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055043 · Cited by 38
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
Koh, Y., Matreyek, K. A., & Engelman, A. (2011) · Journal of Virology · doi:10.1128/jvi.02541-10 · Cited by 37
“(PFV) (48), suggesting that they, like NRTIs, might harbor”
BackgroundSites of retroviral DNA integration: From basic research to clinical applications
Serrao, E., & Engelman, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1102859 · Cited by 36
“…exhibit reproducible tDNA nucleotide preferences at integration sites (Ballandras-Colas et al., 2013; Bor et al., 1996; Chou et al., 1996; Holman & Coffin, 2005; Leclercq et al., 2000; Serrao et al., 2015; Shih et al., 1988; Stevens & Griffith, 1996; Valkov et al., 2009; Wu et al., 2005).”
BackgroundRetroviral intasomes search for a target DNA by 1D diffusion which rarely results in integration
Jones, N. D., Lopez, M. A., Hanne, J., Peake, M. B., Lee, J., Fishel, R. A., & Yoder, K. E. (2016) · Nature Communications · doi:10.1038/ncomms11409 · Cited by 34
Nucleoprotein complex intermediates in HIV-1 integration
Li, M., & Craigie, R. (2009) · Methods · doi:10.1016/j.ymeth.2009.02.001 · Cited by 33
Corvaglia, V., Carbajo, D., Prabhakaran, P., Ziach, K., Mandal, P. K., Santos, V. D. O., Legeay, C., Vogel, R., Parissi, V., Pourquier, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz352 · Cited by 32
“HIV-1 IN was purified from bacteria using the same procedure as previously described (46).”
Progress and prospects: Foamy virus vectors enter a new age
Erlwein, O. W., & McClure, M. O. (2010) · Gene Therapy · doi:10.1038/gt.2010.95 · Cited by 30
“Although the PFV IN has little sequence homology to the HIV IN, it was still sensitive to lentiviral strand transfer inhibitors, suggesting that these reagents target highly conserved regions of IN–DNA complexe”
BackgroundSelf-citationHIV-1 Integrase-DNA Recognition Mechanisms
Kessl, J. J., McKee, C. J., Eidahl, J. O., Shkriabai, N., Katz, A., & Kvaratskhelia, M. (2009) · Viruses · doi:10.3390/v1030713 · Cited by 32
“For example, recombinant prototype foamy virus IN from the Spumavirus genus is highly soluble and robustly catalyzes the concerted integration reactions with 16-bps substrates [132], thus presenting an intriguing model for detailed structural analysis.”
BackgroundDNA minicircles clarify the specific role of DNA structure on retroviral integration
Pasi, M., Mornico, D., Volant, S., Juchet, A., Batisse, J., Bouchier, C., Parissi, V., Ruff, M., Lavery, R., & Lavigne, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw651 · Cited by 29
“HIV-1 IN, the HIV-1 IN–LEDGF/p75 complex and PFV IN were purified as described in (21,45,46).”
MethodThe Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
Hare, S., & Cherepanov, P. (2009) · Viruses · doi:10.3390/v1030780 · Cited by 28
“INs from equine infectious anemia virus (EIAV) and prototype foamy virus (PFV) promote predominantly concerted integration in vitro [30,64].”
BackgroundSelf-citationReigadas, S., Masquelier, B., Calmels, C., Laguerre, M. S., Lazaro, E., Vandenhende, M. A., Neau, D., Fleury, H. J., & Andréola, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00071-11 · Cited by 27
“Raltegravir and elvitegravir inhibit PFV IN in vitro, indicating that the active sites of the FPV and HIV enzymes are quite similar (38).”
BackgroundComparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors
Gupta, P. K., Garg, P., & Roy, N. (2011) · Molecular Diversity · doi:10.1007/s11030-011-9304-7 · Cited by 27
Hassounah, S. A., Mésplède, T., Quashie, P. K., Oliveira, M., Sandstrom, P. A., & Wainberg, M. A. (2014) · Journal of Virology · doi:10.1128/jvi.00947-14 · Cited by 26
“Despite a difference in amino acid position Q148 in PFV, the latter retained susceptibility to RAL, further supporting the use of PFV in our model (58).”
ResultRetroviral integrase protein and intasome nucleoprotein complex structures
Grawenhoff, J., & Engelman, A. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.32 · Cited by 27
Li, X., Koh, Y., & Engelman, A. (2012) · Journal of Virology · doi:10.1128/jvi.06386-11 · Cited by 24
“Unlike PFV IN (115), HIV-1 IN is unable to efficiently integrate relatively short vDNA substrates into target DNA in a concerted fashion in the absence of added binding factors (13, 53).”
BackgroundSirous, H., Fassihi, A., Brogi, S., Campiani, G., Christ, F., Debyser, Z., Gemma, S., Butini, S., Chemi, G., Grillo, A., et al. (2018) · Medicinal Chemistry · doi:10.2174/1573406415666181219113225 · Cited by 24
Multifunctional facets of retrovirus integrase
Grandgenett, D. P., Pandey, K. K., Bera, S., & Aihara, H. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.83 · Cited by 23
Tsiang, M., Jones, G. S., Hung, M., Samuel, D., Novikov, N. Y., Mukund, S., Brendza, K. M., Niedziela‐Majka, A., Jin, D., Liu, X., et al. (2011) · Biochemistry · doi:10.1021/bi101504w · Cited by 22
“4-14 nM) at DTT concentrations of 1-10 mM which are commonly used for IN activity assays (55-60).”
Hu, J., He, H.-Q., Tang, D., Guo-feng, S., Zhang, Y., Fan, J., & Chang, S. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.709458 · Cited by 22
“Previous experimental studies (Valkov et al., 2009) show that PFV IN is sensitive to HIV-1 IN inhibitor including DKA molecules, which suggests that both PFV IN and HIV-1 IN have a similar functional conservation.”
BackgroundHIVToolbox, an Integrated Web Application for Investigating HIV
Sargeant, D. P., Deverasetty, S., Luo, Y., Baleta, A. V., Zobrist, S., Rathnayake, V. R., Russo, J. C., Vyas, J., Muesing, M. A., & Schiller, M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020122 · Cited by 22
“We also used a recent structural model of the Prototypic Foamy Virus IN (PFV IN) to create a HIV-1 IN model, and analyzed this model with HIVToolbox [9].”
BackgroundMethodRetroviral integrase: Structure, mechanism, and inhibition
Passos, D. O., Li, M., Craigie, R., & Lyumkis, D. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.06.007 · Cited by 23
“The key breakthrough in high-resolution structural studies of retroviral intasomes came from Cherepanov and colleagues finding that prototype foamy virus (PFV) IN is highly active in vitro and soluble [38].”
BackgroundNucleoprotein Intermediates in HIV-1 DNA Integration: Structure and Function of HIV-1 Intasomes
Craigie, R. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-10-8456-0_9 · Cited by 21
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript (Valkov et al. 2009).”
BackgroundPathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance
Malet, I., Ambrosio, F. A., Subra, F., Herrmann, B., Leh, H., Bouger, M.-C., Artese, A., Katlama, C., Talarico, C., Romeo, I., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx529 · Cited by 21
The successes and failures of HIV drug discovery
Hashimoto, C., Tanaka, T., Narumi, T., Nomura, W., & Tamamura, H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.611129 · Cited by 19
“The crystal structure of human foamy virus IN with viral DNA can be used as an alternative [91,92].”
Biochemical Characterization of Novel Retroviral Integrase Proteins
Ballandras-Colas, A., Naraharisetty, H., Li, X., Serrao, E., & Engelman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076638 · Cited by 18
“Despite these limitations, X-ray crystal structures of the spumavirus prototype foamy virus (PFV) intasome that represent the salient nucleoprotein complexes along the first three steps in the integration pathway have been determined [4–6].”
BackgroundMethodInfluentialStructural basis of Ty3 retrotransposon integration at RNA Polymerase III-transcribed genes
Abascal-Palacios, G., Jochem, L., Pla‐Prats, C., Beuron, F., & Vannini, A. (2021) · Nature Communications · doi:10.1038/s41467-021-27338-w · Cited by 18
Shi, K., Pandey, K. K., Bera, S., Vora, A. C., Grandgenett, D. P., & Aihara, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056892 · Cited by 18
“, 6 base-pairs (bp) for avian Rous sarcoma virus (RSV), 5 bp for HIV, and 4 bp for murine leukemia virus and prototype foamy virus (PFV) [1,2].”
BackgroundAraújo, A. R., Ribeiro, A. J. M., Fernandes, P. A., & Ramos, M. J. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct500570g · Cited by 16
Li, M., Lin, S., & Craigie, R. (2015) · Protein Science · doi:10.1002/pro.2837 · Cited by 16
“Protein expression and purification Full-length PFV integrase was expressed and purified as described.(11) The hyperactive HIV-1 integrase Sso7d-IN was used for this study.”
MethodFoamy virus assembly with emphasis on Pol encapsidation
Lee, E.-G., Stenbak, C., & Linial, M. (2013) · Viruses · doi:10.3390/v5030886 · Cited by 15
“FV reverse transcription occurs during virus assembly and/or budding, resulting in dsDNA-containing infectious virions.”
BackgroundInfluentialPathogenicity and Rapid Growth Kinetics of Feline Immunodeficiency Virus Are Linked to 3′ Elements
Thompson, J., MacMillan, M., Boegler, K. A., Wood, C. A., Elder, J. H., & VandeWoude, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024020 · Cited by 14
“Further, FIV Pol C813 may be a component of secondary structural motifs important for integrase function, as this region is part of alphahelix-1 in HIV [35], along with SIV [36], primate foamy virus [37], and Rous sarcoma virus [38] integrases.”
BackgroundRaltegravir in HIV-1 Infection: Safety and Efficacy in Treatment-Naïve Patients
Pandey, K. K. (2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s5022 · Cited by 14
Modeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors
Yin, Z., & Craigie, R. (2010) · Viruses · doi:10.3390/v2122777 · Cited by 13
“The breakthrough in structural studies of intasomes came from the discovery that PFV integrase displays much more favorable properties for biophysical studies than its HIV-1 counterpart [11].”
BackgroundHIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex
Bera, S., Pandey, K. K., Vora, A. C., & Grandgenett, D. P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.043 · Cited by 13
Engelman, A., & Cherepanov, P. (2020) · FEBS Journal · doi:10.1111/febs.15438 · Cited by 12
Self-citationThe Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario
Renzi, G., Carta, F., & Supuran, C. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512187 · Cited by 12
Yeast and the AIDS Virus: The Odd Couple
Andréola, M., & Litvak, S. (2012) · BioMed Research International · doi:10.1155/2012/549020 · Cited by 12
Rostami, M. R., Sirous, H., Zabihollahi, R., Aghasadeghi, M. R., Sadat, S. M., Namazi, R., Saghaie, L., Memarian, H. R., & Fassihi, A. (2015) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1443-4 · Cited by 12
“…the high level of conservation between retroviral INs, in particular within their active sites (Engelman and Craigie, 1992; Kulkosky et al., 1992; Valkov et al., 2009), these crystal structures of PFV intasome containing viral DNA can serve as a convenient proxy for structural studies and…”
Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses
Lee, G.-E., Mauro, E., Parissi, V., Shin, C., & Lesbats, P. (2019) · Viruses · doi:10.3390/v11090770 · Cited by 11
“Despite the limited sequence similarity and different intasome architecture features (lentiviral: tetramer-of-tetramer, PFV: dimer-of-dimer), PFV IN was highly sensitive to HIV INSTIs [8,73], suggesting that INSTIs target the most conserved regions of IN-DNA complexes.”
BackgroundEbrahimzadeh, E., Tabatabai, S. A., Vahabpour, R., Hajimahdi, Z., & Zarghi, A. (2019) · PubMed Central · doi:10.22037/ijpr.2019.112198.13597 · Cited by 11
Soluble expression, purification and characterization of the full length IS2 Transposase
Lewis, L. A., Astatke, M., Umekubo, P. T., Alvi, S., Saby, R., & Afrose, J. (2011) · Mobile DNA · doi:10.1186/1759-8753-2-14 · Cited by 11
“Structure-based alignments in Figure 10 were determined from the sequences shown in Figure 7, from published RSV and HIV-1 sequences [73,109,110] from the alignments of Fayet et al.”
MethodRemoval of nuclease contamination during purification of recombinant prototype foamy virus integrase
Lopez, M. A., Mackler, R. M., & Yoder, K. E. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.06.002 · Cited by 11
Pharmacophore-based database mining for probing fragmental drug-likeness of diketo acid analogues
Bąk, A., Magdziarz, T., & Polański, J. (2012) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2011.645875 · Cited by 11
“However, the cocrystal structures of the prototype foamy virus complexed with RAL and ELG have been recently reported in the PDB repository, and work as convenient referential geometries for structural studies [34,35].”
MethodAssembly and Purification of Prototype Foamy Virus Intasomes
Mackler, R. M., Lopez, M. A., & Yoder, K. E. (2018) · Journal of Visualized Experiments · doi:10.3791/57453 · Cited by 11
Mackler, R. M., Jones, N. D., Gardner, A. M., Lopez, M. A., Howard, C. J., Fishel, R. A., & Yoder, K. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212764 · Cited by 10
Host Factors in Retroviral Integration and the Selection of Integration Target Sites
Craigie, R., & Bushman, F. D. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch45 · Cited by 10
Sirous, H., Zabihollahi, R., Aghasadeghi, M. R., Sadat, S. M., Saghaie, L., & Fassihi, A. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1289-1 · Cited by 10
“However, due to the high level of conservation between retroviral INs, in particular within their active sites (Engelman and Craigie, 1992; Kulkosky et al., 1992; Valkov et al., 2009), PFV-IN can serve as a convenient proxy for structural studies and development of HIV-1 integrase strand transfer inhibitors (Krishnan…”
Hu, J., Liu, M., Tang, D., & Chang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054929 · Cited by 9
“In addition, Valkov’s biological experiment [21] shows that the in vitro ST activity of PFV IN is ablated in the presence of .”
BackgroundDevelopment of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors
Quevedo, M. A., Ribone, S. R., Briñón, M. C., & Dehaen, W. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2014.06.007 · Cited by 9
HIV-1 Integrase Drug Discovery Comes of Age
Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 9
Pandey, K. K., Bera, S., Korolev, S., Campbell, M. A., Yin, Z., Aihara, H., & Grandgenett, D. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573311 · Cited by 9
“The STIs also inhibit strand transfer mediated by PFV IN and inhibit its replication (18).”
BackgroundLopez, M. A., Mackler, R. M., Altman, M. P., & Yoder, K. E. (2017) · Journal of Visualized Experiments · doi:10.3791/56605-v · Cited by 9
Prospective Strategies for Targeting HIV-1 Integrase Function
Luo, Y., & Muesing, M. A. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.205 · Cited by 9
Brief Histories of Retroviral Integration Research and Associated International Conferences
Grandgenett, D. P., & Engelman, A. (2024) · Viruses · doi:10.3390/v16040604 · Cited by 8
“…Other INs, such as those derived from Moloney murine leukemia virus (Mo-MLV) [3], avian myeloblastosis virus (AMV) [7], prototype foamy virus (PFV) [13], or mouse mammary tumor virus [14], possess robust concerted integration activities, which, after deproteination, yield reaction products that…”
BackgroundMethodInfluential
Metadata
- Authors
- Valkov, E., Gupta, S. S., Hare, S., Helander, A., Roversi, P., McClure, M., & Cherepanov, P.
- Affiliations
- Imperial College London (GB)
- University of Oxford (GB)
- Corresponding author
- Cherepanov, Peter
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11-26
- Volume
- 37
- Issue
- 1
- Pages
- 243-255
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC2615609
- OpenAlex
- W2001281718
- Cited by
- 130
- References
- 86
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 2 · 2021: 7 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 9 · 2016: 5 · 2015: 15 · 2014: 12 · 2013: 10 · 2012: 13
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by-nc)
- Figshare (submittedVersion, cc-by-nc)
- Funders
- European Synchrotron Radiation Facility
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retroviral integrase, integrase strand transfer inhibitors, HIV-1 integrase, proviral integration
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Crystallography, Dogs, Enzyme Inhibitors, Humans, Models, Molecular, Molecular Sequence Data, Recombinant Proteins, Viral Proteins, Spumavirus, Sequence Analysis, DNA, Integrases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.